- Conditions: Mucopolysaccharidosis I; Mucopolysaccharidosis VI; Adrenoleukodystrophy; Niemann-Pick Disease; Metachromatic Leukodystrophy; Wolman Disease; Krabbe's Disease; Gaucher's Disease; Fucosidosis; Batten Disease; Severe Aplastic Anemia; Diamond-Blackfan Anemia; Amegakaryocytic Thrombocytopenia; Myelodysplastic Syndrome; Acute Myelogenous Leukemia; Acute Lymphocytic Leukemia
Intervention: Drug: Human Placental Derived Stem Cell
Sponsors: New York Medical College; New York Medical College
Not yet recruiting - verified April 2012 - Conditions: Axial and Peripheral Spondyloarthritis; Rheumatoid Arthritis
Interventions: Drug: administration of Cimzia®; Drug: Immunoscintigraphy with radiolabeled Cimzia®.
Sponsors: University Hospital, Ghent; University Hospital, Ghent; UCB Pharma SA
Not yet recruiting - verified May 2012 - Condition: Chronic Fatigue Syndrome
Interventions: Drug: Sodium oxybate; Drug: Placebo
Sponsors: University Hospital, Ghent; University Hospital, Ghent; UCB, Inc.
Not yet recruiting - verified April 2012 - Conditions: Rheumatoid Arthritis; Crohn's Disease
Intervention:
Sponsors: UCB, Inc.; UCB, Inc.
Recruiting - verified April 2012 - Condition: Sickle Cell Disease
Intervention: Drug: NiCord
Sponsors: Gamida Cell ltd; Gamida Cell ltd
Recruiting - verified May 2012 - Condition: Crohns Disease
Intervention: Drug: Certolizumab
Sponsors: Baylor College of Medicine; Baylor College of Medicine; UCB, Inc.
Recruiting - verified April 2012 - Condition: Restless Legs Syndrome
Intervention: Drug: Rotigotine
Sponsors: UCB, Inc.; UCB, Inc.
Recruiting - verified April 2012 - Condition: Healthy Volunteers
Interventions: Drug: Rotigotine PR 2.1.4; Drug: Rotigotine PR 2.2.1
Sponsors: UCB, Inc.; UCB, Inc.; Otsuka Pharmaceutical Co., Ltd.
Recruiting - verified March 2012 - Condition: Fed
Interventions: Drug: Levocetirizine Dihydrochloride tablets 5 mg; Drug: Levocetirizine Dihydrochloride
Sponsors: IPCA Laboratories Ltd.; IPCA Laboratories Ltd.
Completed - verified March 2012 - Condition: Juvenile Idiopathic Arthritis (JIA)
Intervention: Drug: Certolizumab Pegol (CZP)
Sponsors: UCB, Inc.; UCB, Inc.
Recruiting - verified May 2012 - Condition: Fasting State
Intervention: Drug: Levocetirizine Dihydrochloride 5 mg Tablets
Sponsors: IPCA Laboratories Ltd.; IPCA Laboratories Ltd.
Completed - verified March 2012 - Conditions: Cord Blood Transplant; Hematologic Malignancy; Inherited Metabolic Disease
Intervention: Drug: TXA127
Sponsors: US Biotest, Inc.; US Biotest, Inc.; Tarix Pharmaceuticals
Recruiting - verified March 2012 - Conditions: Graft-Versus-Host Disease; GVHD; Allogeneic Hematopoietic Transplant; Disorder Related to Transplantation
Intervention: Biological: Human umbilical cord blood-derived mesenchymal stem cells
Sponsors: Samsung Medical Center; Samsung Medical Center; Medipost Co Ltd.
Recruiting - verified March 2012 - Conditions: Restless Legs Syndrome; End-Stage Renal Disease
Interventions: Drug: Rotigotine; Drug: Placebo
Sponsors: UCB, Inc.; UCB, Inc.
Recruiting - verified April 2012 - Condition: Advanced Parkinson's Disease
Interventions: Drug: Rotigotine; Drug: Placebo
Sponsors: UCB, Inc.; UCB, Inc.
Recruiting - verified February 2012 - Condition: Systemic Lupus Erythematosus
Intervention: Biological: Epratuzumab
Sponsors: UCB, Inc.; UCB, Inc.
Enrolling by invitation - verified April 2012 - Condition: Rheumatoid Arthritis
Intervention: Biological: Olokizumab
Sponsors: UCB, Inc.; UCB, Inc.
Enrolling by invitation - verified May 2012 - Condition: Healthy Subjects
Intervention: Drug: Lacosamide
Sponsors: UCB, Inc.; UCB, Inc.
Recruiting - verified February 2012 - Condition: Healthy
Interventions: Drug: Lacosamide (LCM); Drug: Carbamazepine Immediate Release (CBZ-IR)
Sponsors: UCB, Inc.; UCB, Inc.
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: UCB, Inc.; UCB, Inc.; ReSearch Pharmaceutical Services, Inc.
Recruiting - verified May 2012 - Conditions: Non-Hodgkin's Lymphoma (NHL); Hodgkin's Disease; Chronic Lymphocytic Leukemia (CLL); Acute Myelogenous Leukemia (AML); Acute Lymphoblastic Leukemia (ALL); MDS
Intervention: Biological: Single FT1050 treated UCB unit
Sponsors: Fate Therapeutics; Fate Therapeutics
Recruiting - verified February 2012 - Condition: Healthy Volunteers
Interventions: Other: Lacosamide; Other: Warfarin
Sponsors: UCB, Inc.; UCB, Inc.
Completed - verified May 2012 - Condition: Idiopathic Parkinson's Disease
Interventions: Drug: Rotigotine; Drug: Placebo Patch
Sponsors: UCB, Inc.; UCB, Inc.
Recruiting - verified April 2012 - Sleep Efficiency Assessed by Polysomnography (PSG Sleep Lab Testing) in Advanced Parkinson's DiseaseCondition: Advanced Idiopathic Parkinson's Disease
Interventions: Other: Placebo; Other: Rotigotine
Sponsors: UCB, Inc.; UCB, Inc.
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Interventions: Biological: Certolizumab Pegol + Methotrexate (MTX); Biological: Placebo + Methotrexate (MTX)
Sponsors: UCB, Inc.; UCB, Inc.
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Interventions: Biological: Certolizumab Pegol + Methotrexate (MTX); Biological: Placebo + Methotrexate (MTX)
Sponsors: UCB, Inc.; UCB, Inc.
Not yet recruiting - verified January 2012 - Conditions: Epilepsy; Partial Onset Seizures
Interventions: Drug: Levetiracetam (LEV); Drug: Levetiracetam (LEV)
Sponsors: UCB, Inc.; UCB, Inc.
Recruiting - verified May 2012 - Condition: Parkinson's Disease
Intervention:
Sponsors: UCB, Inc.; UCB, Inc.; Pivotal S.L.
Recruiting - verified May 2012 - Condition: Healthy
Intervention: Drug: Levocetirizine DiHCl
Sponsors: Dr. Reddy's Laboratories Limited; Dr. Reddy's Laboratories Limited
Completed - verified January 2012 - Condition: Fasting
Intervention: Drug: Levocetirizine DiHCl
Sponsors: Dr. Reddy's Laboratories Limited; Dr. Reddy's Laboratories Limited
Completed - verified January 2012 - Condition: Rheumatoid Arthritis
Interventions: Biological: Certolizumab pegol + Methotrexate (CZP + MTX); Biological: Adalimumab + Methotrexate (ADA + MTX)
Sponsors: UCB, Inc.; UCB, Inc.
Recruiting - verified May 2012 - Condition: Epilepsy
Interventions: Drug: Levetiracetam; Drug: Oxcarbazepine
Sponsors: UCB, Inc.; UCB, Inc.
Recruiting - verified April 2012 - Condition: Restless Legs Syndrome
Intervention: Drug: Rotigotine
Sponsors: UCB, Inc.; UCB, Inc.
Recruiting - verified April 2012 - Condition: Restless Legs Syndrome
Intervention: Drug: Rotigotine
Sponsors: UCB, Inc.; UCB, Inc.
Recruiting - verified May 2012 - Conditions: Healthy Subjects; Renal Impairments
Interventions: Drug: Levetiracetam 250 mg; Drug: Levetiracetam 500 mg
Sponsors: UCB, Inc.; UCB, Inc.; Parexel
Recruiting - verified April 2012 - Condition: Cerebral Palsy
Interventions: Biological: Umbilical Cord Blood Infusion; Other: Active Rehabilitation; Other: Placebo Umbilical Cord Blood
Sponsors: Sung Kwang Medical Foundation; Sung Kwang Medical Foundation
Suspended - verified January 2012 - Condition: Epilepsy
Intervention: Drug: Lacosamide
Sponsors: UCB, Inc.; UCB, Inc.
Recruiting - verified May 2012 - Condition: Hematologic Malignancies
Intervention: Biological: StemEx
Sponsors: Loyola University; Loyola University; Gamida Cell ltd
Recruiting - verified November 2011 - Conditions: Acute Myelogenous Leukemia; Acute Lymphocytic Leukemia; Chronic Lymphocytic Leukemia; Chronic Myelogenous Leukemia; Hodgkins Disease; Non-Hodgkins Lymphoma; Aplastic Anemia; Multiple Myeloma; Myelodysplastic Syndrome
Interventions: Drug: Busulfan; Drug: Clofarabine; Drug: Fludarabine; Drug: Melphalan; Drug: Carmustine; Drug: Etoposide; Drug: Cytarabine
Sponsors: Texas Oncology Cancer Center; Texas Oncology Cancer Center
Recruiting - verified December 2011 - Conditions: Acute Myelogenous Leukemia; Refractory Acute Myelogenous Leukemia
Interventions: Drug: Allopurinol; Drug: Fludarabine; Radiation: Total body irradiation; Drug: Cyclophosphamide; Drug: Levetiracetam; Drug: Busulfan; Biological: Umbilical Cord Blood Transplantation; Biological: Interleukin-2
Sponsors: Masonic Cancer Center, University of Minnesota; Masonic Cancer Center, University of Minnesota
Recruiting - verified November 2011 - Conditions: Epilepsy; Monotherapy
Interventions: Drug: Lacosamide; Drug: Carbamazepine-Controlled Release (CBZ-CR)
Sponsors: UCB, Inc.; UCB, Inc.; EDEV S.À.R.L
Not yet recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Interventions: Biological: Placebo; Biological: Olokizumab 60 mg; Biological: Olokizumab 120 mg; Biological: Olokizumab 240 mg
Sponsors: UCB, Inc.; UCB, Inc.
Recruiting - verified April 2012 - Condition: Umbilical Cord Blood Transplant
Intervention: Biological: Umbilical Cord Blood (UCB) Units
Sponsors: Masonic Cancer Center, University of Minnesota; Masonic Cancer Center, University of Minnesota
Recruiting - verified December 2011 - Condition: Restless Legs Syndrome
Interventions: Drug: Rotigotine; Drug: Placebo
Sponsors: UCB, Inc.; UCB, Inc.
Active, not recruiting - verified April 2012 - Condition: Nonconvulsive Seizures
Interventions: Drug: Lacosamide; Drug: Fosphenytoin
Sponsors: Duke Clinical Research Institute; Duke Clinical Research Institute; UCB, Inc.
Not yet recruiting - verified October 2011 - Condition: Traumatic Brain Injury
Intervention: Biological: Allogeneic Umbilical Cord Blood
Sponsors: Sung Kwang Medical Foundation; Sung Kwang Medical Foundation
Not yet recruiting - verified October 2011 - Condition: Epilepsy
Interventions: Drug: Lacosamide; Drug: Lacosamide; Drug: Lacosamide; Other: Placebo; Other: Placebo; Other: Placebo
Sponsors: UCB, Inc.; UCB, Inc.
Completed - verified October 2011 - Condition: Systemic Lupus Erythematosus
Interventions: Biological: Placebo; Biological: Epratuzumab 400 mg; Biological: Epratuzumab 1200 mg; Biological: Epratuzumab 100 mg; Biological: Epratuzumab 600 mg
Sponsors: UCB, Inc.; UCB, Inc.
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Intervention: Biological: Certolizumab pegol
Sponsors: UCB, Inc.; UCB, Inc.
Recruiting - verified April 2012 - Condition: Hypoplastic Left Heart Syndrome
Interventions: Other: Autologous Umbilical Cord Blood; Other: Autologous Umbilical Cord Blood
Sponsors: Duke University; Duke University
Recruiting - verified September 2011 - Condition: Rheumatoid Arthritis
Interventions: Drug: placebo of CDP870; Drug: CDP870
Sponsors: Otsuka Pharmaceutical Co., Ltd.; Otsuka Pharmaceutical Co., Ltd.; UCB Japan Co., LTD.
Recruiting - verified May 2012 - Conditions: Ischemic Stroke; Ischaemic Cerebral Infarction; Infarction, Middle Cerebral Artery; Ischemia; Brain Ischemia
Intervention: Procedure: Intercerebral implantation of allogenic CD34+ stem cell
Sponsors: China Medical University Hospital; China Medical University Hospital
Not yet recruiting - verified September 2011 - Condition: Migraine Disorders
Interventions: Drug: Non-steroidal anti-inflammatory drug (NSAID); Drug: Triptan
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified September 2011 - Condition: Brain Cancer
Interventions: Drug: Lacosamide; Other: Placebo
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center; BRAIN TUMOR TRIALS COLLABORATIVE (BTTC); UCB, Inc.
Not yet recruiting - verified March 2012 - Condition: Iron Deficiency Anemia
Interventions: Drug: Ferrous (II) Glycine Sulphate Complex; Drug: Polyferose
Sponsors: UCB, Inc.; UCB, Inc.
Suspended - verified April 2012 - Condition: Systemic Lupus Erythematosus
Intervention: Drug: Epratuzumab
Sponsors: UCB, Inc.; UCB, Inc.
Enrolling by invitation - verified May 2012 - Condition: Epilepsy, Partial Onset Seizures
Intervention: Drug: Levetiracetam
Sponsors: UCB, Inc.; UCB, Inc.
Recruiting - verified March 2012 - Condition: Epilepsy
Intervention: Drug: Brivaracetam
Sponsors: UCB, Inc.; UCB, Inc.
Recruiting - verified May 2012 - Conditions: Epilepsy; Generalized Tonic-clonic Seizures
Intervention: Drug: Levetiracetam
Sponsors: UCB, Inc.; UCB, Inc.
Recruiting - verified April 2012 - Condition: Healthy Volunteers
Interventions: Drug: Levetiracetam; Drug: Levetiracetam
Sponsors: UCB, Inc.; UCB, Inc.
Completed - verified October 2011 - Condition: Epilepsy
Intervention: Drug: Anti-epileptic drug (AED)
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified February 2012 - Condition: Restless Legs Syndrome
Intervention:
Sponsors: UCB, Inc.; UCB, Inc.
Enrolling by invitation - verified May 2012 - Condition: Migraine Disorders
Interventions: Drug: Combination therapy with sumatriptan and naproxen sodium (SumaRT/Nap); Drug: Single-entity oral triptans
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Active, not recruiting - verified June 2011 - Condition: Migraine Disorders
Interventions: Drug: Combination therapy of sumatriptan and naproxen sodium (SumaRT/Nap); Drug: Triptan monotherapy
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Active, not recruiting - verified June 2011 - Condition: Rheumatoid Arthritis
Interventions: Drug: Open Label Drug Certolizumab Pegol (CZP); Procedure: Arthroscopic synovial tissue biopsy
Sponsors: Arthritis Treatment Center, Maryland; Nathan Wei, MD, FACP, FACR:; University of California, San Diego
Recruiting - verified September 2011 - Condition: Healthy Male Volunteers
Interventions: Drug: Lacosamide; Drug: Placebo; Drug: Carbamazepine
Sponsors: University of Kiel; University of Kiel; UCB S.A.
Recruiting - verified March 2011 - Condition: Epilepsy
Intervention: Drug: Brivaracetam
Sponsors: UCB, Inc.; UCB, Inc.
Enrolling by invitation - verified March 2012
 |
UCB - Database of Clinical Trials by Pharmaceutical Companies |
